Innovations in Biologic Therapeutics

  • ID: 4209601
  • Report
  • 15 pages
  • Frost & Sullivan
1 of 3
This Genetic Technology TOE depicts trends across biologic therapeutics. With every therapy that is being discovered, there are subsequent discoveries made on the ideal candidates for these therapies. Unfortunately, due to the genetic and cellular variability present in diseases such as cancer, certain therapies are more suitable for a specific strata of patients. The emergence of cell-based therapies and gene therapies will slowly revolutionize personalized therapeutics across diseases that are difficult to treat. The corresponding patent scenario is depicted, along with the industry interactions.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Note: Product cover images may vary from those shown
2 of 3
Innovation Profiles
  • Chimeric Antigen Receptor T Cell Therapy for Haematological Malignancies
  • Molecular Switches for CAR-based T Cell Therapies
  • Computational Immunology Techniques Aid in Vaccine Development
  • Platform Technologies for Better Next Gen Biologic Therapeutics
  • Stem Cell Trends
  • Industry Contacts
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll